CERO

CERo Therapeutics Holdings, Inc. CERO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CERO LIMN XRTX OCEA GLMD NKGN BIVI ELAB BCTXZ MLEC
6M -99.09 % -94.64 % -34.83 % -85.71 % -53.56 % -80.00 % -86.45 % -67.83 % -61.76 % -95.13 %
YTD -99.92 % -84.57 % -51.38 % -99.83 % -73.84 % -92.76 % -93.60 % -96.18 % -70.23 % -95.98 %
1Y -99.90 % -84.57 % -49.21 % -99.84 % -71.34 % -92.22 % -93.23 % -96.37 % -70.23 % -95.90 %
3Y -100.00 % -84.57 % -91.34 % -99.99 % -99.18 % -99.12 % -99.80 % -99.99 % -70.23 % -96.51 %
5Y -100.00 % -84.57 % -97.99 % -99.99 % -99.87 % -99.12 % -99.91 % -99.99 % -70.23 % -96.64 %
10Y -100.00 % -84.57 % -97.99 % -99.99 % -99.94 % -99.12 % -99.07 % -99.99 % -70.23 % -96.64 %
From the beginning -100.00 % -84.57 % -97.99 % -99.99 % -99.97 % -99.12 % -99.63 % -99.99 % -70.23 % -96.64 %

Dividend

XORTX Therapeutics Inc.